
The project required the translation of a high-level performance specification into a technically coordinated laboratory design tailored to the specific operational requirements of a pharmaceutical manufacturer. Establishing efficient workflows was critical, particularly in coordinating the movement of inputs, products and waste streams while maintaining separation between teams and product lines. The client demanded a tight programme from RIBA Stage 2 through to completion, alongside the need to navigate the planning process and incorporate sustainability objectives, including the ambition to achieve BREEAM accreditation.

Fatkin worked collaboratively with Novus Space and the client team to analyse and refine the initial design through a series of stakeholder workshops, translating operational requirements into a coordinated architectural solution. Particular attention was given to workflow efficiency, team and product line separation, and the mapping of incoming materials, finished products and waste streams to support the laboratory's day-to-day operation. The design integrates the selected modular MMC system with the client's specialist requirements. Fatkin also managed the planning application through both pre-application engagement and the detailed submission stages, helping to progress the project within the demanding programme. Sustainability was integrated throughout, with the facility designed to achieve BREEAM accreditation.

The new facility provides Rosemont Pharmaceuticals with a purpose-designed environment that supports efficient research and production processes, improves operational workflow and incorporates sustainability objectives, including the ambition to achieve BREEAM accreditation.







